Back to News
Market Impact: 0.2
JP Morgan Initiates Coverage of Electra Therapeutics at Overweight
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
JP Morgan initiated coverage of Electra Therapeutics with an Overweight recommendation on October 22, 2026. The stock's pre-action close was $9.05 on October 21; the article is truncated before providing a complete latest closing price.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Tesla is falling even after earnings. What analysts are saying
- J.P. Morgan backs Benelux insurers on valuation discount, shareholder returns
- Unauthorized AI agents are reportedly already accessing US bank accounts
- Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
- Moderna shares plunge after leak of partial cancer vaccine data
- A lesson from poker tells us not to fold on Meta after its earnings sell-off. Here’s why
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Live Event Center, In-App Documents, and Faster Transcripts
- How to Automate Equity Research Workflows: A Control-First Guide